The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProven Vct Regulatory News (PVN)

Share Price Information for Proven Vct (PVN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.172%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 59.50
PVN Live PriceLast checked at -
ProVen VCT is an Investment Trust

To achieve long-term returns from investing in a portfolio of quoted companies, qualifying investments in small and medium sized unquoted companies and non-qualifying investments permitted for liquidity management purposes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Offer for Subscription

27 Jan 2020 16:53



Statement re Offer for Subscription

ProVen VCT plcProVen Growth and Income VCT plc27 January 2020Offer for Subscription

ProVen VCT plc and ProVen Growth and Income VCT plc (the “Companies”) announce that they have today published a Prospectus (comprising a Securities Note, Registration Document and Summary) in respect of an offer for subscription to raise up to £20,000,000 by way of an issue of new ordinary shares ("New Ordinary Shares") in the Companies, each raising up to £10,000,000, with an over-allotment facility of up to a further £20,000,000 in aggregate (being up to £10,000,000 for each of the Companies), payable in full in cash on application (the “Offer”).

The Offer opens on 27 January 2020 and will close not later than 5.00 pm on 2 April 2020 in respect of the 2019/2020 Offer and not later than 1.00 pm on 30 April 2020 in respect of the 2020/2021 Offer, or as soon as the Offer is fully subscribed. The directors of each of the Companies may decide to extend the Offer in respect of their Company at their absolute discretion to a date no later than 31 December 2020.

Applicants (and their spouses) who had an existing shareholding in one of the Companies on 27 January 2020, and whose valid Application forms part of the first £5 million of valid Applications for each Company and is received by 1 p.m. on 21 February 2020, will be entitled to additional New Ordinary Shares with an aggregate subscription price equivalent to1.5% of the amount subscribed. 

All other Applicants whose valid Application forms part of the first £5 million of valid Applications for each Company and is received by 1 p.m. on 21 February 2020 will be entitled to additional New Ordinary Shares with an aggregate subscription price equivalent to 0.75% of the amount subscribed.

The subscription price of the additional New Ordinary Shares to be received by early applicants will be met by Beringea LLP, the Companies' investment manager ("Beringea").

Pursuant to an agreement dated 27 January 2020 between, inter alia, the Companies and Beringea LLP, Beringea will receive a fee (the "Fee") for acting as promoter of the Offer equal to five and a half (5.5) per cent. of the gross funds raised under the Offer from applications received directly from investors and three (3) per cent. of the gross funds raised under the Offer from applications received through a financial adviser or an execution-only brokers. Out of the Fee Beringea will pay all costs, agreed between the Companies and Beringea, including charges and expenses, of or incidental to the Offer.

Pursuant to a deed of variation dated 27 January 2020, the investment management agreement (the "ProVen IMA") between ProVen VCT plc and Beringea will be varied as a result of the Offer to provide for an increase in the compensation payable to Beringea in the event of an early termination of the ProVen IMA. The maximum amount of such additional compensation payable is the equivalent of 2% per annum of the net proceeds of the Offer received by ProVen, payable until 28 February 2023.

Pursuant to a deed of variation dated 27 January 2020, the investment management agreement (the "PGI IMA") between ProVen Growth & Income VCT plc and Beringea will be varied as a result of the Offer to provide for an increase in the compensation payable to Beringea in the event of an early termination of the PGI IMA. The maximum amount of such compensation payable is the equivalent of 2% per annum of the net proceeds of the Offer received by PGI, payable until 28 February 2023.

The Fee and the above amendments to the ProVen IMA and the PGI IMA are small related party transactions between each of the Companies and Beringea under Listing Rule 11.1.10R.

In addition to the related party transactions described above, Malcolm Moss, a director of both Companies intends to invest £10,000 in each of the Companies under the Offer. Beringea is an associate of Mr Moss under the Listing Rules and, accordingly, the payment of the Fee and the above amendments to the ProVen IMA and the PGI IMA are required under the Listing Rules to be aggregated with Mr Moss's intended subscriptions. On an aggregated basis all of these proposed transactions are small related party transactions between Mr Moss and each of the Companies under Listing Rule 11.1.10R

To obtain a copy of the Securities Note, investors and Financial Advisers should call the investment manager, Beringea, on 020 7845 7820. A downloadable version of the Securities Note is also available from www.provenvcts.co.uk.

A copy of the Prospectus is available, free of charge, from the registered office of the Company or from:

Beringea LLP39 Earlham StreetLondon WC2H 9LT

Copies of the Prospectus will be submitted to the National Storage Mechanism and will shortly be available for viewing online at the following web-site address:

www.morningstar.co.uk/uk/NSM.

For further information please contact:Shane Elliott on 020 7845 7820Beringea LLPCompany SecretaryTelephone 020 7845 7820

-End


Date   Source Headline
28th Feb 20055:22 pmRNSNet Asset Value(s)
14th Feb 200512:52 pmRNSTransaction in Own Shares
8th Feb 20054:13 pmRNSTransaction in Own Shares
25th Jan 200511:22 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.